Lynparza is FDA-approved to treat advanced ovarian cancer, fallopian tube cancer, peritoneal cancer, HER2-negative breast cancer, pancreatic adenocarcinoma, and metastatic castration-resistant prostate cancer, particularly in patients with BRCA mutations or HRD-positive status.
Alert: Order your 3-month supply by October 12 to help avoid potential customs delays.
Get Semaglutide for $184 or Ozempic for $329
